CD9 and hepatocellular carcinoma: Beyond the head and neck, in hepatocellular carcinoma, tetraspanins CD9 and CD81 are tumor suppressive: CD81 is frequently lost in tumor tissue, and reduced CD9/CD81 expression correlates with advanced stage and poorer outcomes [63].